Showing results (311-320 of 339) with videos related to

Sort By:
Pageof 34
Journal of Liver Cancer|January 21, 2024
Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosisJeayeon Park, Yun Bin Lee, Yunmi Ko, et al.
European Radiology|October 25, 2025
Hepatocellular carcinoma risk stratification to identify patients suitable for intensive surveillance in viral hepatitis: the SELECT scoreYeun-Yoon Kim, Won Chang, Jeong Min Lee, et al.
Antimicrobial Agents and Chemotherapy|August 27, 2014
Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strainsYun Bin Lee, Jeong-Hoon Lee, Dong Hyeon Lee, et al.
Cancers|November 7, 2019
Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort StudyJun Sik Yoon, Dong Hyun Sinn, Jeong-Hoon Lee, et al.
Journal of Liver Cancer|March 4, 2025
Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer RegistryJihyun An, Young Chang, Gwang Hyeon Choi, et al.
Intervirology|January 25, 2013
Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrenceDong Hyeon Lee, Yuri Cho, Ji Yeon Seo, et al.
Hepatology (Baltimore, Md.)|March 11, 2024
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort studySung Won Chung, Hye-Sung Moon, Hyunjae Shin, et al.
Cancers|September 6, 2019
Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up StudyYoung Chang, Yuri Cho, Jeong-Hoon Lee, et al.
Hepatology (Baltimore, Md.)|April 26, 2017
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinomaJae-Kyung Won, Su Jong Yu, Chae Young Hwang, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trialHyunjae Shin, Youngsu Park, Byeong Geun Song, et al.
Pageof 34